Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation AHA 2023

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Presenter: Jeff Healey

November 16, 2023

Presentation AHA 2023

AZALEA-TIMI 71

Presenter: Christian T. Ruff

November 15, 2023

Presentation AHA 2023

Efficacy and safety of anticoagulation with edoxaban in patients with Atrial high rate-episodes (AHRE) durations ≥ 24 hours - The NOAH-AFNET 6 trial

Presenter: Nina Becher

November 14, 2023

Presentation ESC 2023

Randomized Controlled Trial for Pulsed Field Ablation versus Standard of Care Thermal Ablation for Paroxysmal Atrial Fibrillation: Primary Results of the ADVENT Trial

Presenter: Vivek Y. Reddy

August 28, 2023

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

Presentation ACC 2023

Pulsed Field Ablation Treatment in Paroxysmal and Persistent Atrial Fibrillation Patients: Acute and Long-term Outcomes from the PULSED AF Pivotal Trial

Presenter: Atul Verma

March 05, 2023

Presentation Miami Valves 2023

A Revolutionary Approach to Left Atrial Appendage Closure

Presenter: Saibal Kar

February 04, 2023

Presentation Miami Valves 2023

Wearable Defibrillators

Presenter: Alex Velasquez

February 03, 2023

Presentation Miami Valves 2023

50 years of Sudden Cardiac Death Prevention: Progress, Promises, and Pitfalls

Presenter: Robert J. Myerburg

February 03, 2023

Presentation Miami Valves 2023

Implementation of the shock team

Presenter: Rohan Goswami

February 02, 2023

Advertisement

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

AZALEA-TIMI 71

Efficacy and safety of anticoagulation with edoxaban in patients with Atrial high rate-episodes (AHRE) durations ≥ 24 hours - The NOAH-AFNET 6 trial

Randomized Controlled Trial for Pulsed Field Ablation versus Standard of Care Thermal Ablation for Paroxysmal Atrial Fibrillation: Primary Results of the ADVENT Trial

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Pulsed Field Ablation Treatment in Paroxysmal and Persistent Atrial Fibrillation Patients: Acute and Long-term Outcomes from the PULSED AF Pivotal Trial

A Revolutionary Approach to Left Atrial Appendage Closure

Wearable Defibrillators

50 years of Sudden Cardiac Death Prevention: Progress, Promises, and Pitfalls

Implementation of the shock team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content